HMGB1 and diabetic kidney disease: We and others have also shown evidence for TGFβ induced activation of the innate immunity pathway in diabetic nephropathy, in particular Toll like receptor 2 (TLR2) and its endogenous ligand High Mobility Group Box 1 (HMGB1) [13], [14].